Search
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 3 of 3 items.
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
AlertHealth professional risk communication | 2018-03-16
0.9% Sodium Chloride Injection, 250 mL (2018-03-16)
RecallHealth product recall | 2018-03-16
Phenylbutazone powder (2018-03-02)
RecallHealth product recall | 2018-03-02